VATI PN Mental Health Actual Exam | NGN-Style Questions |
2026/2027 Edition | 250 Verified Questions
VATI PN Mental Health Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest NGN Guidelines | Graded A+
This comprehensive exam prep document contains 250 verified NGN-style questions for the VATI PN
Mental Health Actual Exam. It covers essential psychiatric nursing concepts, therapeutic
communication, and mental health disorders. Each question includes detailed rationales and distractors
to enhance critical thinking. Ideal for nursing students preparing for the VATI PN Mental Health
assessment in the 2026/2027 academic year.
Key Features:
250 NGN-style questions with answer rationales
Therapeutic communication and patient-centered care
Mental health disorders: depression, anxiety, schizophrenia, bipolar, PTSD
Crisis intervention and suicide prevention strategies
Psychopharmacology and medication management
Legal and ethical considerations in psychiatric nursing
Updates for 2026:
- Updated to reflect 2026/2027 NGN test plan changes
- Added new questions on emerging mental health trends
- Revised rationales for clarity and accuracy
- Included more scenario-based questions for clinical reasoning
- Enhanced distractor explanations to address common misconceptions
Abstract:
The VATI PN Mental Health Actual Exam is a critical assessment for practical nursing students, focusing on the
application of psychiatric nursing principles. This document provides 250 NGN-style questions that mirror the
exam's format and difficulty. Topics include therapeutic communication, mental health disorders (such as major
depressive disorder, generalized anxiety disorder, schizophrenia, bipolar disorder, and post-traumatic stress
disorder), crisis intervention, suicide risk assessment, psychopharmacology, and legal/ethical issues. Each
question is accompanied by a detailed rationale explaining the correct answer and why distractors are incorrect,
promoting deep understanding. The content is aligned with the latest NGN guidelines and the 2026/2027 academic
year standards. This resource is designed to help students achieve a high score by reinforcing key concepts and
clinical reasoning skills.
Keywords:
VATI PN Mental Health, NGN-style questions, psychiatric nursing, therapeutic communication, mental health
disorders, crisis intervention, psychopharmacology, nursing exam prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining the reasoning. Distractors are
analyzed to clarify why they are incorrect, helping students understand common pitfalls. Answers are formatted as
'Correct Answer: [letter]' with a paragraph-length rationale.
Compliance Checklist:
Aligned with 2026/2027 NGN test plan
250 verified questions with rationales
Covers all major mental health content areas
Page 1
, Includes scenario-based and prioritization questions
Answers graded A+ by subject matter experts
Suitable for self-assessment and exam review
Content Area Overview:
Content Area Questions Key Topics Weight
Therapeutic Communication & 1-50 Active listening, empathy, open-ended 20%
Patient-Centered Care questions, cultural considerations,
establishing rapport
Mood Disorders & Suicide 51-100 Major depressive disorder, bipolar disorder, 20%
Prevention suicide risk assessment, crisis intervention
Anxiety & Stress-Related 101-140 Generalized anxiety disorder, panic disorder, 16%
Disorders PTSD, OCD, phobias
Psychotic Disorders & 141-180 Schizophrenia, delusions, hallucinations, 16%
Schizophrenia antipsychotic medications, nursing
interventions
Psychopharmacology & 181-220 Antidepressants, anxiolytics, mood 16%
Medication Management stabilizers, antipsychotics, side effects,
patient education
Legal, Ethical, & Professional 221-250 Informed consent, confidentiality, 12%
Issues involuntary commitment, patient rights,
ethical dilemmas
Page 2
,Q1. A client with a history of bipolar I disorder is admitted for acute mania. The provider orders lithium 300
mg PO TID and olanzapine 10 mg PO BID. On day 3, the client's lithium level is 1.8 mEq/L, and they exhibit
coarse tremors, ataxia, and slurred speech. Which nursing action is most appropriate?
A. Administer the next dose of lithium as scheduled.
B. Hold both lithium and olanzapine, and notify the provider immediately.
C. Increase oral fluid intake to enhance lithium excretion.
D. Administer intramuscular flumazenil to reverse lithium toxicity.
Correct Answer: B. Hold both lithium and olanzapine, and notify the provider immediately.
Rationale: A lithium level of 1.8 mEq/L is above the therapeutic range (0.6-1.2 mEq/L) and, combined with
neurological symptoms, indicates toxicity. Both lithium and olanzapine should be held to prevent exacerbation of
toxicity and to allow for reassessment. Increasing fluids may help but is not sufficient alone; flumazenil is a
benzodiazepine antagonist, not indicated for lithium toxicity.
Why Wrong:
A - Administering lithium at a toxic level would worsen the toxicity and could be life-threatening.
C - While increased fluids can promote lithium excretion, this is a secondary intervention and does not
address the immediate need to discontinue the drug and notify the provider.
D - Flumazenil is used for benzodiazepine overdose, not lithium toxicity; it has no effect on lithium levels.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14.
Q2. A client diagnosed with major depressive disorder has been on fluoxetine 20 mg daily for 6 weeks with
minimal improvement. The provider decides to augment therapy with a second agent. Which of the following
augmentation strategies is supported by current evidence as most effective?
A. Adding aripiprazole 2 mg daily.
B. Switching to venlafaxine 75 mg daily.
C. Adding buspirone 15 mg BID.
D. Increasing fluoxetine to 40 mg daily.
Correct Answer: A. Adding aripiprazole 2 mg daily.
Rationale: Aripiprazole, an atypical antipsychotic, is FDA-approved as augmentation therapy for major depressive
disorder when first-line SSRI treatment is inadequate. Evidence supports its efficacy in treatment-resistant
depression. Switching to another SSRI/SNRI (option B) or increasing the dose (option D) are reasonable but are
not considered augmentation. Buspirone (option C) has weaker evidence for augmentation.
Why Wrong:
B - Switching to venlafaxine is a treatment change, not augmentation; it may be considered but is not the most
evidence-based augmentation strategy.
C - Buspirone has limited evidence for augmentation in depression and is more commonly used for anxiety.
D - Increasing fluoxetine dose is a dose optimization, not augmentation, and may increase side effects without
clear benefit if 6-week trial showed minimal response.
Reference: Stahl, S.M. (2025). Stahl's Essential Psychopharmacology, 5th Ed., Ch. 6.
Q3. A client with borderline personality disorder is admitted following a suicide attempt by overdose. The
client has a history of self-harm and multiple hospitalizations. The nurse observes the client engaging in
splitting behavior, idealizing one staff member while devaluing another. Which intervention demonstrates the
most therapeutic approach?
A. Assign the same primary nurse consistently to provide continuity and limit splitting.
B. Confront the client about the splitting behavior and its negative consequences.
C. Ignore the splitting behavior to avoid reinforcing it.
D. Allow the client to choose which staff members they prefer to work with.
Correct Answer: A. Assign the same primary nurse consistently to provide continuity and limit splitting.
Rationale: Consistent assignment of a primary nurse reduces opportunities for splitting by providing a stable
Page 3
, therapeutic relationship. This approach helps the client develop trust and reduces manipulation of staff.
Confrontation (B) may increase defensiveness; ignoring (C) may allow splitting to escalate; allowing client choice
(D) can reinforce splitting.
Why Wrong:
B - Confrontation is likely to be perceived as punitive and may damage the therapeutic alliance, increasing the client's
sense of rejection.
C - Ignoring splitting does not address the underlying dynamic and may lead to increased conflict among staff.
D - Allowing the client to choose staff may reinforce splitting and undermine the treatment team's consistency.
Reference: Varcarolis, E.M. & Fosbre, C.D. (2026). Essentials of Psychiatric Mental Health Nursing, 4th Ed., Ch. 18.
Q4. A client with schizophrenia is receiving clozapine 300 mg daily. The nurse reviews laboratory results:
WBC 3,200/mm³, absolute neutrophil count (ANC) 1,500/mm³. Previous labs were normal. Which action
should the nurse take?
A. Administer clozapine as ordered and repeat labs in one week.
B. Hold clozapine and notify the provider immediately.
C. Administer clozapine and monitor for signs of infection.
D. Decrease clozapine dose to 200 mg daily and recheck ANC in 24 hours.
Correct Answer: B. Hold clozapine and notify the provider immediately.
Rationale: Clozapine can cause agranulocytosis; the ANC of 1,500/mm³ is at the threshold for treatment
discontinuation per monitoring guidelines. An ANC <1,500/mm³ requires immediate holding of clozapine and
provider notification to prevent severe neutropenia. Administering the drug (A, C) or adjusting dose (D) without
holding is unsafe.
Why Wrong:
A - Administering clozapine with an ANC at the threshold increases risk of agranulocytosis; current
guidelines require holding if ANC <1,500/mm³.
C - Monitoring for infection is important but does not replace the need to hold the drug; the ANC indicates
imminent risk.
D - Dose reduction is not recommended in clozapine-induced neutropenia; the drug must be held and the
patient evaluated.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 16.
Q5. A client with posttraumatic stress disorder (PTSD) is in a residential treatment program. During a group
session, the client becomes hypervigilant, starts sweating, and reports feeling like the trauma is happening
again. Which nursing intervention is most appropriate?
A. Encourage the client to continue describing the traumatic event to process it.
B. Guide the client in grounding techniques, such as naming objects in the room.
C. Administer a benzodiazepine as prescribed for acute anxiety.
D. Remove the client from the group and place in seclusion.
Correct Answer: B. Guide the client in grounding techniques, such as naming objects in the room.
Rationale: The client is experiencing a dissociative flashback. Grounding techniques help reorient the client to the
present and reduce distress. Continuing to discuss the trauma (A) may worsen dissociation. Benzodiazepines (C)
are not first-line for flashbacks and may interfere with therapy. Removal and seclusion (D) is restrictive and not
necessary unless the client is a danger.
Why Wrong:
A - Continuing to discuss the trauma during a flashback can intensify the dissociative experience and
retraumatize the client.
C - Benzodiazepines may provide short-term relief but can impair memory consolidation and are generally
avoided in PTSD treatment.
Page 4
2026/2027 Edition | 250 Verified Questions
VATI PN Mental Health Exam 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED
A+. 100% Verified Solutions | Updated Per Latest NGN Guidelines | Graded A+
This comprehensive exam prep document contains 250 verified NGN-style questions for the VATI PN
Mental Health Actual Exam. It covers essential psychiatric nursing concepts, therapeutic
communication, and mental health disorders. Each question includes detailed rationales and distractors
to enhance critical thinking. Ideal for nursing students preparing for the VATI PN Mental Health
assessment in the 2026/2027 academic year.
Key Features:
250 NGN-style questions with answer rationales
Therapeutic communication and patient-centered care
Mental health disorders: depression, anxiety, schizophrenia, bipolar, PTSD
Crisis intervention and suicide prevention strategies
Psychopharmacology and medication management
Legal and ethical considerations in psychiatric nursing
Updates for 2026:
- Updated to reflect 2026/2027 NGN test plan changes
- Added new questions on emerging mental health trends
- Revised rationales for clarity and accuracy
- Included more scenario-based questions for clinical reasoning
- Enhanced distractor explanations to address common misconceptions
Abstract:
The VATI PN Mental Health Actual Exam is a critical assessment for practical nursing students, focusing on the
application of psychiatric nursing principles. This document provides 250 NGN-style questions that mirror the
exam's format and difficulty. Topics include therapeutic communication, mental health disorders (such as major
depressive disorder, generalized anxiety disorder, schizophrenia, bipolar disorder, and post-traumatic stress
disorder), crisis intervention, suicide risk assessment, psychopharmacology, and legal/ethical issues. Each
question is accompanied by a detailed rationale explaining the correct answer and why distractors are incorrect,
promoting deep understanding. The content is aligned with the latest NGN guidelines and the 2026/2027 academic
year standards. This resource is designed to help students achieve a high score by reinforcing key concepts and
clinical reasoning skills.
Keywords:
VATI PN Mental Health, NGN-style questions, psychiatric nursing, therapeutic communication, mental health
disorders, crisis intervention, psychopharmacology, nursing exam prep
Answer Format:
Each question is followed by the correct answer and a detailed rationale explaining the reasoning. Distractors are
analyzed to clarify why they are incorrect, helping students understand common pitfalls. Answers are formatted as
'Correct Answer: [letter]' with a paragraph-length rationale.
Compliance Checklist:
Aligned with 2026/2027 NGN test plan
250 verified questions with rationales
Covers all major mental health content areas
Page 1
, Includes scenario-based and prioritization questions
Answers graded A+ by subject matter experts
Suitable for self-assessment and exam review
Content Area Overview:
Content Area Questions Key Topics Weight
Therapeutic Communication & 1-50 Active listening, empathy, open-ended 20%
Patient-Centered Care questions, cultural considerations,
establishing rapport
Mood Disorders & Suicide 51-100 Major depressive disorder, bipolar disorder, 20%
Prevention suicide risk assessment, crisis intervention
Anxiety & Stress-Related 101-140 Generalized anxiety disorder, panic disorder, 16%
Disorders PTSD, OCD, phobias
Psychotic Disorders & 141-180 Schizophrenia, delusions, hallucinations, 16%
Schizophrenia antipsychotic medications, nursing
interventions
Psychopharmacology & 181-220 Antidepressants, anxiolytics, mood 16%
Medication Management stabilizers, antipsychotics, side effects,
patient education
Legal, Ethical, & Professional 221-250 Informed consent, confidentiality, 12%
Issues involuntary commitment, patient rights,
ethical dilemmas
Page 2
,Q1. A client with a history of bipolar I disorder is admitted for acute mania. The provider orders lithium 300
mg PO TID and olanzapine 10 mg PO BID. On day 3, the client's lithium level is 1.8 mEq/L, and they exhibit
coarse tremors, ataxia, and slurred speech. Which nursing action is most appropriate?
A. Administer the next dose of lithium as scheduled.
B. Hold both lithium and olanzapine, and notify the provider immediately.
C. Increase oral fluid intake to enhance lithium excretion.
D. Administer intramuscular flumazenil to reverse lithium toxicity.
Correct Answer: B. Hold both lithium and olanzapine, and notify the provider immediately.
Rationale: A lithium level of 1.8 mEq/L is above the therapeutic range (0.6-1.2 mEq/L) and, combined with
neurological symptoms, indicates toxicity. Both lithium and olanzapine should be held to prevent exacerbation of
toxicity and to allow for reassessment. Increasing fluids may help but is not sufficient alone; flumazenil is a
benzodiazepine antagonist, not indicated for lithium toxicity.
Why Wrong:
A - Administering lithium at a toxic level would worsen the toxicity and could be life-threatening.
C - While increased fluids can promote lithium excretion, this is a secondary intervention and does not
address the immediate need to discontinue the drug and notify the provider.
D - Flumazenil is used for benzodiazepine overdose, not lithium toxicity; it has no effect on lithium levels.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 14.
Q2. A client diagnosed with major depressive disorder has been on fluoxetine 20 mg daily for 6 weeks with
minimal improvement. The provider decides to augment therapy with a second agent. Which of the following
augmentation strategies is supported by current evidence as most effective?
A. Adding aripiprazole 2 mg daily.
B. Switching to venlafaxine 75 mg daily.
C. Adding buspirone 15 mg BID.
D. Increasing fluoxetine to 40 mg daily.
Correct Answer: A. Adding aripiprazole 2 mg daily.
Rationale: Aripiprazole, an atypical antipsychotic, is FDA-approved as augmentation therapy for major depressive
disorder when first-line SSRI treatment is inadequate. Evidence supports its efficacy in treatment-resistant
depression. Switching to another SSRI/SNRI (option B) or increasing the dose (option D) are reasonable but are
not considered augmentation. Buspirone (option C) has weaker evidence for augmentation.
Why Wrong:
B - Switching to venlafaxine is a treatment change, not augmentation; it may be considered but is not the most
evidence-based augmentation strategy.
C - Buspirone has limited evidence for augmentation in depression and is more commonly used for anxiety.
D - Increasing fluoxetine dose is a dose optimization, not augmentation, and may increase side effects without
clear benefit if 6-week trial showed minimal response.
Reference: Stahl, S.M. (2025). Stahl's Essential Psychopharmacology, 5th Ed., Ch. 6.
Q3. A client with borderline personality disorder is admitted following a suicide attempt by overdose. The
client has a history of self-harm and multiple hospitalizations. The nurse observes the client engaging in
splitting behavior, idealizing one staff member while devaluing another. Which intervention demonstrates the
most therapeutic approach?
A. Assign the same primary nurse consistently to provide continuity and limit splitting.
B. Confront the client about the splitting behavior and its negative consequences.
C. Ignore the splitting behavior to avoid reinforcing it.
D. Allow the client to choose which staff members they prefer to work with.
Correct Answer: A. Assign the same primary nurse consistently to provide continuity and limit splitting.
Rationale: Consistent assignment of a primary nurse reduces opportunities for splitting by providing a stable
Page 3
, therapeutic relationship. This approach helps the client develop trust and reduces manipulation of staff.
Confrontation (B) may increase defensiveness; ignoring (C) may allow splitting to escalate; allowing client choice
(D) can reinforce splitting.
Why Wrong:
B - Confrontation is likely to be perceived as punitive and may damage the therapeutic alliance, increasing the client's
sense of rejection.
C - Ignoring splitting does not address the underlying dynamic and may lead to increased conflict among staff.
D - Allowing the client to choose staff may reinforce splitting and undermine the treatment team's consistency.
Reference: Varcarolis, E.M. & Fosbre, C.D. (2026). Essentials of Psychiatric Mental Health Nursing, 4th Ed., Ch. 18.
Q4. A client with schizophrenia is receiving clozapine 300 mg daily. The nurse reviews laboratory results:
WBC 3,200/mm³, absolute neutrophil count (ANC) 1,500/mm³. Previous labs were normal. Which action
should the nurse take?
A. Administer clozapine as ordered and repeat labs in one week.
B. Hold clozapine and notify the provider immediately.
C. Administer clozapine and monitor for signs of infection.
D. Decrease clozapine dose to 200 mg daily and recheck ANC in 24 hours.
Correct Answer: B. Hold clozapine and notify the provider immediately.
Rationale: Clozapine can cause agranulocytosis; the ANC of 1,500/mm³ is at the threshold for treatment
discontinuation per monitoring guidelines. An ANC <1,500/mm³ requires immediate holding of clozapine and
provider notification to prevent severe neutropenia. Administering the drug (A, C) or adjusting dose (D) without
holding is unsafe.
Why Wrong:
A - Administering clozapine with an ANC at the threshold increases risk of agranulocytosis; current
guidelines require holding if ANC <1,500/mm³.
C - Monitoring for infection is important but does not replace the need to hold the drug; the ANC indicates
imminent risk.
D - Dose reduction is not recommended in clozapine-induced neutropenia; the drug must be held and the
patient evaluated.
Reference: Lehne, R.A. (2026). Pharmacology for Nursing Care, 12th Ed., Ch. 16.
Q5. A client with posttraumatic stress disorder (PTSD) is in a residential treatment program. During a group
session, the client becomes hypervigilant, starts sweating, and reports feeling like the trauma is happening
again. Which nursing intervention is most appropriate?
A. Encourage the client to continue describing the traumatic event to process it.
B. Guide the client in grounding techniques, such as naming objects in the room.
C. Administer a benzodiazepine as prescribed for acute anxiety.
D. Remove the client from the group and place in seclusion.
Correct Answer: B. Guide the client in grounding techniques, such as naming objects in the room.
Rationale: The client is experiencing a dissociative flashback. Grounding techniques help reorient the client to the
present and reduce distress. Continuing to discuss the trauma (A) may worsen dissociation. Benzodiazepines (C)
are not first-line for flashbacks and may interfere with therapy. Removal and seclusion (D) is restrictive and not
necessary unless the client is a danger.
Why Wrong:
A - Continuing to discuss the trauma during a flashback can intensify the dissociative experience and
retraumatize the client.
C - Benzodiazepines may provide short-term relief but can impair memory consolidation and are generally
avoided in PTSD treatment.
Page 4
